Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial
Titel:
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial
Auteur:
Delany-Moretlwe, Sinead Lombard, Carl Baron, Deborah Bekker, Linda-Gail Nkala, Busi Ahmed, Khatija Sebe, Modulakgotla Brumskine, William Nchabeleng, Maposhane Palanee-Philips, Thesla Ntshangase, Julius Sibiya, Sidney Smith, Emilee Panchia, Ravindre Myer, Landon Schwartz, Jill L Marzinke, Mark Morris, Lynn Brown, Elizabeth R Doncel, Gustavo F Gray, Glenda Rees, Helen